Scholarlink

<p>The heme catabolism pathway is often elevated in aggressive cancers; however, the impact of this pathway and some of its byproducts on the tumor microenvironment remain largely unknown. In human breast cancers, tumor expression of the heme catabolizing enzyme heme oxygenase-1 (HO-1/<i>HMOX1</i>) is positively associated with macrophage abundance. In mouse mammary tumors, knockdown of <i>Hmox1</i> significantly decreased tumor growth and lung metastasis. Analysis of mammary tumor interstitial fluid compared to matching plasma revealed that the heme metabolite bilirubin was elevated intratumorally, which could be partially reversed via <i>Hmox1</i> knockdown. Further investigation revealed that bilirubin nearly ablates macrophage engulfment of dead tumor cells and significantly increases macrophage T cell suppression. Mammary tumors harboring <i>Hmox1</i> knockdown had a significant decrease in tumor growth rate and number of pro-metastatic CD206<sup>+</sup> macrophages upon treatment with αPD-1. Depletion of intratumoral bilirubin levels impacts pro-tumor macrophage populations, particularly in combination with immunotherapy, demonstrating that heme catabolism and bilirubin act as immunomodulators in cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Aggressive breast cancers secrete heme metabolites to alter macrophage immune suppression and function

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月9日

查看全文
  • Michelle M. Williams,
  • Jessica L. Christenson,
  • Nicole S. Spoelstra,
  • Sabrina A. Hafeez,
  • Li-Wei Kuo,
  • Lyndsey S. Crump,
  • Kathleen I. O’Neill,
  • Alexis A. Hill,
  • Angelica Phan,
  • Lauren M. McCue,
  • Thomas M. Hintelmann,
  • Juanantonio Ruiz,
  • Haley E. Sax,
  • Jared Williams,
  • Meher Preethi Boorgula,
  • Andrew Goodspeed,
  • Jill E. Slansky,
  • Jennifer K. Richer

摘要

The heme catabolism pathway is often elevated in aggressive cancers; however, the impact of this pathway and some of its byproducts on the tumor microenvironment remain largely unknown. In human breast cancers, tumor expression of the heme catabolizing enzyme heme oxygenase-1 (HO-1/HMOX1) is positively associated with macrophage abundance. In mouse mammary tumors, knockdown of Hmox1 significantly decreased tumor growth and lung metastasis. Analysis of mammary tumor interstitial fluid compared to matching plasma revealed that the heme metabolite bilirubin was elevated intratumorally, which could be partially reversed via Hmox1 knockdown. Further investigation revealed that bilirubin nearly ablates macrophage engulfment of dead tumor cells and significantly increases macrophage T cell suppression. Mammary tumors harboring Hmox1 knockdown had a significant decrease in tumor growth rate and number of pro-metastatic CD206+ macrophages upon treatment with αPD-1. Depletion of intratumoral bilirubin levels impacts pro-tumor macrophage populations, particularly in combination with immunotherapy, demonstrating that heme catabolism and bilirubin act as immunomodulators in cancer.